ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 1 مورد

Miconazole (topical): Pediatric drug information

Miconazole (topical): Pediatric drug information
2025© UpToDate, Inc. and its affiliates and/or licensors. All Rights Reserved.
For additional information see "Miconazole (topical): Drug information" and "Miconazole (topical): Patient drug information"

For abbreviations, symbols, and age group definitions show table
Brand Names: US
  • Aloe Vesta Antifungal [OTC];
  • Aloe Vesta Clear Antifungal [OTC] [DSC];
  • Antifungal [OTC];
  • Azolen Anti-Fungal Wash [OTC];
  • Azolen Tincture [OTC];
  • Baza Antifungal [OTC];
  • Cavilon [OTC] [DSC];
  • Critic-Aid Clear AF [OTC];
  • Cruex Prescription Strength [OTC];
  • Desenex Jock Itch [OTC];
  • Desenex [OTC];
  • FT Antifungal [OTC];
  • FT Miconazole 3 Comb Pack-Supp [OTC];
  • FT Miconazole 3 Combo Pack [OTC];
  • FT Miconazole 7 [OTC];
  • Fungizyl AC [DSC];
  • Fungizyl AL;
  • Fungoid Tincture [OTC];
  • GoodSense Anti-Fungal [OTC];
  • GoodSense Miconazole 1 [OTC] [DSC];
  • Lotrimin AF Deodorant Powder [OTC] [DSC];
  • Lotrimin AF Jock Itch Powder [OTC] [DSC];
  • Lotrimin AF Powder [OTC] [DSC];
  • Medpura Antifungal [OTC];
  • Micaderm [OTC];
  • Micatin [OTC];
  • Miconazole 3;
  • Miconazole 3 Combo Pack [OTC];
  • Miconazole 3 Combo-Supp [OTC];
  • Miconazole 7 [OTC];
  • Miconazole Antifungal [OTC];
  • Miconi-AL [OTC] [DSC];
  • Micotrin AP [OTC];
  • Micro Guard [OTC];
  • Mycozyl AP [OTC];
  • Secura Antifungal Extra Thick [OTC];
  • Zeasorb-AF [OTC]
Therapeutic Category
  • Antifungal Agent, Topical;
  • Antifungal Agent, Vaginal
Dosing: Pediatric

Dosage guidance:

Dosage form information: Approved indications and ages vary by product; consult product-specific labeling for details.

Candidiasis, vulvovaginal

Candidiasis, vulvovaginal: Note: Many products are available as a combination pack (contains a suppository for vaginal instillation and external cream which is applied twice daily for up to 7 days to relieve external symptoms).

Children ≥12 years and Adolescents:

Cream 2%: Intravaginal: Insert 1 applicatorful (100 mg) at bedtime for 7 consecutive days.

Cream 4%: Intravaginal: Insert 1 applicatorful (200 mg) at bedtime for 3 consecutive days.

Suppository, 100 mg: Intravaginal: Insert 1 suppository at bedtime for 7 days.

Suppository, 200 mg: Intravaginal: Insert 1 suppository at bedtime for 3 days.

Suppository, 1,200 mg: Intravaginal: Insert 1 suppository (a one-time dose); may be used at bedtime or during the day.

Dermatologic infection, superficial

Dermatologic infection, superficial: Children ≥2 years and Adolescents: Ointment: Topical: Apply to affected area twice daily.

Tinea corporis

Tinea corporis (ringworm): Children and Adolescents: Limited data available in ages <2 years: 2%: Topical cream, powder, aerosol powder, ointment, or solution: Topical: Apply twice daily to affected and surrounding area(s) until clinical resolution, typically 2 to 4 weeks (Ref).

Tinea cruris

Tinea cruris (jock itch): Children and Adolescents: Limited data available in ages <2 years: 2%: Topical cream, powder, aerosol powder, ointment, or solution: Topical: Apply twice daily to affected and surrounding area(s) until clinical resolution, typically 2 weeks (Ref).

Tinea pedis

Tinea pedis (athlete's foot): Children and Adolescents: Limited data available in ages <2 years: 2%: Topical cream, powder, aerosol powder, ointment, or solution: Topical: Apply twice daily to affected and surrounding area(s) until clinical resolution, typically 4 weeks (Ref).

Dosing: Kidney Impairment: Pediatric

There are no dosage adjustments provided in the manufacturer’s labeling.

Dosing: Liver Impairment: Pediatric

There are no dosage adjustments provided in the manufacturer’s labeling.

Dosing: Adult

(For additional information see "Miconazole (topical): Drug information")

Candidiasis, vulvovaginal

Candidiasis , vulvovaginal: Note: Many products are available as a combination pack, with a suppository for vaginal instillation and cream to relieve external symptoms. A longer duration of 7 to 14 days may be necessary in patients with complicated infection (ie, recurrent or severe infection, infection with non-albicans Candida, pregnancy, or infection in an immunocompromised host) (Ref). Not effective against Candida glabrata (Ref).

Cream 2%: Intravaginal: Insert 1 applicatorful (~5 g) once daily (at bedtime) for 7 days (Ref). May also apply externally twice daily for 7 days, as needed, for itching and irritation.

Cream 4%: Intravaginal: Insert 1 applicatorful (~5 g) once daily (at bedtime) for 3 days (Ref). May also apply externally twice daily for 7 days, as needed, for itching and irritation.

Suppository 100 mg: Intravaginal: Insert 1 suppository once daily (at bedtime) for 7 days (Ref).

Suppository 200 mg: Intravaginal: Insert 1 suppository once daily (at bedtime) for 3 days (Ref).

Suppository 1.2 g: Intravaginal: Insert 1 suppository as a single dose (at bedtime or during the day) (Ref).

Tinea infection

Tinea infection:

Tinea corporis/tinea cruris: Topical: Aerosol powder (tinea corporis only), cream, ointment, powder, solution: Apply to affected and surrounding area(s) twice daily until clinical resolution, typically 1 to 4 weeks (Ref).

Tinea pedis/tinea manuum (off-label use): Topical: Aerosol powder, aerosol solution, cream, ointment, powder, solution: Apply to affected and surrounding area(s) twice daily until 1 week after clinical resolution, typically for 4 weeks total (Ref).

Dosing: Kidney Impairment: Adult

There are no dosage adjustments provided in the manufacturer's labeling.

Dosing: Liver Impairment: Adult

There are no dosage adjustments provided in the manufacturer's labeling.

Adverse Reactions

There are no adverse reactions listed in the manufacturer's labeling.

Postmarketing: Dermatologic: Allergic contact dermatitis (Cowan 2022)

Contraindications

Hypersensitivity to miconazole or any component of the formulation.

OTC labeling: When used for self-medication, do not use in children <2 years of age (topical products) or <12 years of age (vaginal products), for diaper rash, nail infections, scalp infections; may be product specific (also consult manufacturer's labeling).

Warnings/Precautions

Concerns related to adverse effects:

• Irritation: Discontinue if sensitivity or irritation occurs.

Dosage form specific issues:

• Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol and/or sodium benzoate/benzoic acid; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity (“gasping syndrome”) in neonates; the “gasping syndrome” consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol and/or benzyl alcohol derivative with caution in neonates. See manufacturer's labeling.

• Flammable contents: Aerosol contains flammable propellants. Avoid fire, flame, and smoking during and immediately following administration.

• Fungoid tincture: Patients with diabetes, circulatory problems, renal or hepatic dysfunction should contact healthcare provider prior to self-medication (OTC use).

• Petrolatum-based: Vaginal products are petrolatum-based and may damage rubber or latex condoms or diaphragms; separate use by 3 days.

• Vaginal products: Consult with health care provider prior to self-medication (OTC use) if experiencing vaginal itching/discomfort, lower abdominal pain, back or shoulder pain, chills, nausea, vomiting, foul-smelling discharge, if this is the first vaginal yeast infection, or if exposed to HIV. Contact health care provider if symptoms do not begin to improve after 3 days or last longer than 7 days. May damage condoms or diaphragms.

Other warnings/precautions:

• Appropriate use: For topical use only; avoid contact with eyes. When used for self-medication (OTC use), contact health care provider if athlete's foot or ringworm does not improve within 4 weeks or if jock itch does not improve within 2 weeks; consult a doctor before using vaginal products if having vaginal itching or discomfort for the first time, lower abdominal pain, back or shoulder pain, fever or chills, nausea or vomiting, or foul-smelling vaginal discharge.

Warnings: Additional Pediatric Considerations

Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, >3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009).

Dosage Forms: US

Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product

Aerosol, External, as nitrate:

GoodSense Anti-Fungal: 2% (150 g) [contains propylene glycol]

Aerosol Powder, External, as nitrate:

Cruex Prescription Strength: 2% (85 g)

Desenex Jock Itch: 2% (113 g)

Lotrimin AF Deodorant Powder: 2% (133 g [DSC])

Lotrimin AF Jock Itch Powder: 2% (133 g [DSC])

Lotrimin AF Powder: 2% (133 g [DSC])

Cream, External:

Fungizyl AC: Miconazole nitrate 2% with dimethyl sulfoxide 2% (85 g [DSC]) [contains cetyl alcohol, disodium edta]

Cream, External, as nitrate:

Antifungal: 2% (14 g [DSC], 28 g [DSC], 42.5 g [DSC]) [contains benzoic acid]

Antifungal: 2% (14.2 g, 28.4 g, 42.5 g) [contains cetostearyl alcohol, chlorocresol (chloro-m-cresol), edetate (edta) disodium, propylene glycol]

Antifungal: 2% (113 g, 198 g) [contains cetyl alcohol, methylparaben, propylene glycol, propylparaben]

Baza Antifungal: 2% (57 g, 142 g) [alcohol free, dye free, latex free, paraben free; contains cetyl alcohol, propylene glycol]

Cavilon: 2% (56 g [DSC], 141 g [DSC]) [latex free; contains disodium edta, methylparaben, propylene glycol, propylparaben]

Desenex: 2% (28 g) [contains benzyl benzoate, cetyl alcohol, propylene glycol]

FT Antifungal: 2% (30 g) [contains benzoic acid]

Medpura Antifungal: 2% (14.2 g, 28.4 g, 42.5 g) [contains cetostearyl alcohol, chlorocresol (chloro-m-cresol), disodium edta, propylene glycol]

Micaderm: 2% (30 g)

Micatin: 2% (14 g) [contains benzoic acid]

Miconazole Antifungal: 2% (30 g) [contains edetate (edta) disodium, ethylparaben, trolamine (triethanolamine)]

Secura Antifungal Extra Thick: 2% (92 g) [contains butylparaben, cetyl alcohol, methylparaben]

Generic: 2% (14 g [DSC], 15 g, 28 g, 30 g, 42.5 g [DSC])

Cream, Vaginal, as nitrate:

FT Miconazole 7: 2% (45 g) [contains benzoic acid]

Miconazole 7: 2% (45 g) [contains benzoic acid]

Generic: 2% (45 g)

Kit, Vaginal, as nitrate:

FT Miconazole 3 Comb Pack-Supp: Cream, topical: 2% (9 g) and Suppository, vaginal: 200 mg (3s) [contains benzoic acid]

FT Miconazole 3 Combo Pack: Cream, topical: 2% (9 g) and Suppository, vaginal: 200 mg (3s) [contains benzoic acid, cetyl alcohol]

GoodSense Miconazole 1: Cream, topical: 2% (9 g) and Suppository, vaginal: 1200 mg [DSC] [contains benzoic acid]

Miconazole 3 Combo Pack: Cream, topical: 2% (9 g) and Suppository, vaginal: 200 mg (3s) [contains benzoic acid, cetyl alcohol, propylene glycol]

Miconazole 3 Combo-Supp: Cream, topical: 2% (9 g) and Suppository, vaginal: 200 mg (3s) [DSC]

Miconazole 3 Combo-Supp: Cream, topical: 2% (9 g) and Suppository, vaginal: 200 mg (3s) [contains benzoic acid]

Generic: Cream, topical: 2% (9 g) and Suppository, vaginal: 200 mg (3s)

Liquid, External:

Fungizyl AL: Miconazole nitrate 2% with dimethyl sulfoxide 2% (30 mL) [contains benzyl alcohol, propylene glycol]

Ointment, External, as nitrate:

Aloe Vesta Antifungal: 2% (56 g, 141 g)

Aloe Vesta Clear Antifungal: 2% (56 g [DSC], 141 g [DSC]) [dye free, fragrance free]

Critic-Aid Clear AF: 2% (57 g)

Powder, External, as nitrate:

Antifungal: 2% (85 g)

Antifungal: 2% (85 g) [paraben free]

Desenex: 2% (43 g, 85 g)

Micotrin AP: 2% (85 g) [contains sodium benzoate]

Micro Guard: 2% (85 g) [contains corn starch]

Mycozyl AP: 2% (85 g) [contains sodium benzoate]

Zeasorb-AF: 2% (71 g) [contains sodium benzoate]

Solution, External, as nitrate:

Azolen Anti-Fungal Wash: 2% (170 g)

Azolen Tincture: 2% (29.57 mL) [contains benzyl alcohol, isopropyl alcohol]

Fungoid Tincture: 2% (29.57 mL) [contains benzyl alcohol]

Miconi-AL: 2% (30 mL [DSC])

Generic: 2% (29.57 mL)

Suppository, Vaginal, as nitrate:

Miconazole 7: 100 mg (7 ea [DSC])

Miconazole 3: 200 mg (3 ea)

Generic Equivalent Available: US

May be product dependent

Pricing: US

Aerosol powder (Cruex Prescription Strength External)

2% (per gram): $0.06

Aerosol powder (Desenex Jock Itch External)

2% (per gram): $0.05

Cream (Desenex External)

2% (per gram): $0.33

Cream (Medpura Antifungal External)

2% (per gram): $0.13

Cream (Micatin External)

2% (per gram): $0.36

Cream (Miconazole Nitrate External)

2% (per gram): $0.18 - $0.24

Cream (Miconazole Nitrate Vaginal)

2% (per gram): $0.25

Cream (Secura Antifungal Extra Thick External)

2% (per gram): $0.11

Liquid (Fungizyl AL External)

2-2% (per mL): $75.00

Ointment (Critic-Aid Clear AF External)

2% (per gram): $0.13

Powder (Desenex External)

2% (per gram): $0.13

Powder (Micotrin AP External)

2% (per gram): $6.50

Powder (Micro Guard External)

2% (per gram): $0.09

Powder (Mycozyl AP External)

2% (per gram): $6.50

Powder (Zeasorb-AF External)

2% (per gram): $0.11

Solution (Azolen Anti-Fungal Wash External)

2% (per gram): $0.12

Solution (Azolen Tincture External)

2% (per mL): $0.59

Solution (Fungoid Tincture External)

2% (per mL): $0.70

Solution (Miconazole Nitrate External)

2% (per mL): $0.59

Disclaimer: A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer. Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions. In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data. Pricing data is updated monthly.

Administration: Pediatric

Topical:

Cream, powder, aerosol powder, ointment, or solution: For external use only. Shake aerosol well prior to use. Apply sparingly and rub gently into the cleansed, dry affected area. For tinea infections, apply to surrounding areas (~1 to 2 cm beyond lesion border) in addition to affected area (Ref). For tinea pedis, pay special attention to spaces between the toes. Wash hands following application.

Vaginal: Wash hands before and after using. Patients should not use intravaginal products (eg, tampons, douches) or engage in vaginal intercourse for the duration of treatment.

Vaginal cream: Gently insert full applicator of cream (prefilled or filled at time of use) high into vagina and press the plunger to release the medication. Discard used prefilled applicators after use; wash reusable applicator with soap and water following use.

Vaginal suppository: Gently insert vaginal suppository high into the vagina.

Administration: Adult

Intravaginal: Creams (with and without applicator), suppository: For vaginal use only. Not for ophthalmic or oral use. Cream may also be applied to the affected and immediate surrounding area(s). Do not use tampons, douches, spermicides, or other vaginal products or have vaginal intercourse during treatment. Wash hands following application.

Topical: Aerosol powder, aerosol solution, cream, ointment, powder, solution: For external use only. Cleanse and thoroughly dry area prior to application. Apply a thin layer to the affected and immediate surrounding area(s). For tinea pedis (athlete's foot), pay special attention to spaces between the toes; wear well fitting, ventilated shoes and change shoes and socks at least once daily. Wash hands following application. Shake aerosol well prior to use.

Storage/Stability

Store at room temperature. The aerosol is flammable; keep away from excessive heat (eg, temperatures >49°C [120°F], fire, flames). Do not puncture or incinerate container.

Use

Topical:

OTC products (do not contain dimethyl sulfoxide [DMSO]):

Cream, spray, powder, aerosol powder: Treatment of tinea corporis, tinea cruris, and tinea pedis and relief of associated itching, cracking, burning, and discomfort (OTC product: FDA approved in ages ≥2 years and adults). Note: Topical therapy is not effective for infection of the scalp or nails.

Ointment: Treatment of tinea corporis, tinea cruris, and tinea pedis; relief of associated itching, cracking, burning, and discomfort from tinea cruris; treatment of superficial infections due to Candida albicans (All indications: OTC product: FDA approved in ages ≥2 years and adults). Note: Topical therapy is not effective for infection of the scalp or nails.

Solution: Treatment of tinea corporis and tinea pedis and relief of itching, scaly skin between the toes (OTC product: FDA approved in ages ≥2 years and adults).

Prescription products (contain DMSO):

Cream (Fungizyl AC), Solution (Fungizyl AL): Treatment of fungal infections of the skin, including tinea pedis, tinea cruris, and tinea corporis; superficial Candida skin infections (All indications: FDA approved in adults).

Vaginal:

Vaginal cream (2%): Treatment of vulvovaginal candidiasis; relief of itching and irritation due to vaginal yeast infection (OTC products: FDA approved in ages ≥12 years and adults).

Vaginal cream (4%) and suppository: Treatment of vulvovaginal candidiasis (OTC products: FDA approved in ages ≥12 years and adults).

Medication Safety Issues
Sound-alike/look-alike issues:

Miconazole may be confused with metroNIDAZOLE, Micronase, Micronor

Lotrimin may be confused with Lotrisone, Otrivin

Micatin may be confused with Miacalcin

Metabolism/Transport Effects

None known.

Drug Interactions

Note: Interacting drugs may not be individually listed below if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed). For a complete list of drug interactions by individual drug name and detailed management recommendations, use the drug interactions program by clicking on the “Launch drug interactions program” link above.

Note: Interacting drugs may not be individually listed below if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed). For a complete list of drug interactions by individual drug name and detailed management recommendations, use the drug interactions program

Progesterone: Antifungal Agents (Vaginal) may decrease therapeutic effects of Progesterone. Risk X: Avoid

Vitamin K Antagonists: Miconazole (Topical) may increase serum concentration of Vitamin K Antagonists. Management: Avoid using any miconazole-containing preparation in patients who are taking warfarin. If coadministration is unavoidable, consider reducing warfarin dose 10% to 20% and monitor for increased warfarin effects (eg, INR, bleeding). Risk D: Consider Therapy Modification

Reproductive Considerations

Vaginal products may weaken latex condoms and diaphragms (CDC [Workowski 2021]).

Pregnancy Considerations

Following vaginal administration, small amounts are absorbed systemically (Stevens 2002).

Outcome data following vaginal use of miconazole during pregnancy are available (Czeizel 2004; Daniel 2018; Papadopoulos 2024; Rotem 2018; Zhou 2024). Some products may contain dimethyl sulfoxide; effects on pregnancy are not known.

Topical azole therapies with 7-day regimens are recommended in pregnant patients with vulvovaginal candidiasis (CDC [Workowski 2021]). Shorter courses of topical azoles are less effective (Young 2001).

Monitoring Parameters

Skin irritation.

Mechanism of Action

Inhibits biosynthesis of ergosterol, damaging the fungal cell wall membrane, which increases permeability causing leaking of nutrients. Some products may contain dimethyl sulfoxide (DMSO) to enhance miconazole penetration.

Pharmacokinetics (Adult Data Unless Noted)

Absorption: Topical: Negligible; Vaginal: Small amount absorbed systemically

Distribution: Into body tissues, joints, and fluids; poor penetration into sputum, saliva, urine, and CSF

Protein binding: 91% to 93%

Metabolism: In the liver

Half-life elimination: Multiphasic degradation: Alpha: 40 minutes; Beta: 126 minutes; Terminal: 24 hours

Excretion: Feces (~50%); urine (<1%, unchanged)

Brand Names: International
International Brand Names by Country
For country code abbreviations (show table)

  • (AE) United Arab Emirates: Candizole | Daktarin | Dermizol | Gyno daktarin | Gyno mikozal | Lotrimin AF Jock Itch Antifungal Powder | Meconasol | Micoglen | Mikozal | Miragel | Mycoheal;
  • (AR) Argentina: Daktarin | Deralbine | Doctor pies hongos | Fabozolam | Ketozol | Miconazol lem | Miconol | Micopul | Micotral | Micotrim P | Monizol | Sinamida fungicida;
  • (AT) Austria: Daktarin | Fungiderm;
  • (AU) Australia: Amcal anti-fungal | Daktarin | Decozol | Gyno-daktarin | Monistat | Monistat 3 | Monistat 7 | Resolve | Resolve tinea | Soul pattinson clotrimazol;
  • (BD) Bangladesh: A migel | Candoral | Fungalin | Fungidal | Fungimin | Gelora | Miaz | Mic | Micoderm | Micofun | Miconex | Micoral | Micosina | Micozol | Mitigal | Myco og | Mycon | Oragel M | Orocare | Oroconazol | Orogurd | Symbiotrin | Topicazole;
  • (BE) Belgium: Daktar | Daktarin | Gyno-daktarin;
  • (BF) Burkina Faso: Fungigen | Mycolex;
  • (BG) Bulgaria: Daktarin | Gyno-daktarin;
  • (BR) Brazil: Anfugitarin | Biodol | Ciconazol | Colpadak | Daktarin | Daktazol | Dermalina | Ginedak | Gino mizonol | Gino-daczol | Ginotarin | Gyno Daknax | Gyno-daktarin | Micofim | Micogyn | Micotarin | Micotics | Micozen | Mizonol | Nitrato de miconazol | Vodol | Volnac;
  • (CH) Switzerland: Daktarin | Monistat;
  • (CI) Côte d'Ivoire: Amicoz | Fungigen | Micazole;
  • (CL) Chile: Daktarin | Dexatrim | Diamifan;
  • (CN) China: An shu ke ning | Ao sha | Bai ni duo | Bei kang | Da ke ning | Daktarin | Ke ning shuan | Le wei | Miconazole;
  • (CO) Colombia: Daktarin | Exazol | Gyno-daktarin;
  • (CZ) Czech Republic: Daktarin | Gyno daktarin;
  • (DE) Germany: Amykon | Daktar | Daktarin | Decomyk | Derma mykotral | Epi-monistat | Fungur m | Gyno Daktar | Gyno-Mykotral | Infectosoor | Micobeta | Miconazol | Miconazol acis | Miconazol saar | Miconazolnitrat 1 A Pharma | Micotar | Mykoderm Miconazol | Mykoderm miconazol | Mykotin | Vobamyk;
  • (DO) Dominican Republic: Daktarin | Darcotin | Gyno-daktarin | Ionil Ecobi | Neomicol | Oz;
  • (EC) Ecuador: Acromizol | Daktarin | Gyno mikozal | Gyno-daktarin | Hongosan | Micatin | Nitrato de miconazol;
  • (EE) Estonia: Daktarin;
  • (EG) Egypt: Adcozole | Buccazole | Daktarin | Dermazol | Dermizol | Dermozole | Gyno daktarin | Gyno-Mykotral | Gynozol | Micazole | Mico oral | Micoban | Miconaz | Miconol | Monicure | Mykotral | Peopodak;
  • (ES) Spain: Daktarin | Fungisdin | Pasedon | Tremix;
  • (ET) Ethiopia: Candizole | Dermozol | Fungigen | Gyno mikozal | Micazole | Miczol | Oromucoral;
  • (FI) Finland: Daktarin | Gyno Daktar | Gyno-daktarin | Gyno-daktarin or | Medizol;
  • (FR) France: Britane | Daktarin | Gyno daktarin;
  • (GB) United Kingdom: Acorvio | Brentan | Daktarin | Daktarin Aktiv | Dermonistat | Femeron | Gyno daktarin | Miconazole | Monistat;
  • (GR) Greece: Daktarin | Fantersol | Fosemyk | Gyno daktarin | Medacter | Mezolitan | Myco flusemidon | Untano;
  • (HK) Hong Kong: Antifungal | Axcel Miconazole | Candiplas | Daktarin | Decozol | Dermon | Funga | Fungtopic | Gyno-daktarin | Miconazole | Microtin | Pharmaniaga miconazole | Tinazol | Uni-Mizole | Zarin;
  • (HR) Croatia: Daktarin | Gyno daktarin | Rojazol;
  • (HU) Hungary: Huma-miconazole;
  • (ID) Indonesia: Daktarin | Daktazol | Delapan delapan | Escortin | Fungares | Funtas | Gyno-daktarin | Locoriz | Mexoderm | Miconazole | Micoskin | Micrem | Moladerm | Mycorine | Mycozol | Nazoderm | Neo kanesol | Nilozanoc | Sporend | Yuphamycorine | Zolagel;
  • (IE) Ireland: Daktarin | Gyno daktarin;
  • (IL) Israel: Daktarin | Gyno Dactarin | Pitrion;
  • (IN) India: Candizol | Canticid | Coniderm | Conzole-m | Daktarin | Depig | Dermizole | Dk gel | Emiconazole | Emzole | Fungiderm | Fungiguard | Fungipic | Fungitop | Gyno-daktarin | Micogel | Miconit | Micoson | Mizol | Rajnish | Rivizole | Ucemic | Zeasorb AF | Zole | Zolive;
  • (IQ) Iraq: Aswaconazole | Micazol | Miconadain | Micozol | Mycoyat | Mycozol;
  • (IT) Italy: Daktarin | Daktarin Dermatologico | Gyno daktarin | Miconal | Micotef | Nizacol | Prilagin;
  • (JO) Jordan: Candiplas | Cyprozol | Daktarin | Dekazol | Gyno Meconasol | Gyno-candizol | Gyno-daktarin | Meconasol | Meconazol | Micover | Micozole | Mikozal | Mycoderm | Mycoheal;
  • (JP) Japan: Amrid | Florid | Florid d | Meditreat | Nitconazone | Pinabelm | Puriden | Sarasilt;
  • (KE) Kenya: Cipconazol | Dacinazole | Daktarin | Dermidex | Domogel | Fugizone | Fungigen | Fungistat | Gyno daktarin | Gyno mikozal | Gyno-candizol | Laeotarin | Micarin | Micnit | Micogel | Micona | Miconaz | Miconazole | Miconex | Micosil | Micoson | Monicure | Oromucoral | Zarin;
  • (KR) Korea, Republic of: Daktarin | Gyno daktarin | Miconal;
  • (KW) Kuwait: Candizole | Daktarin | Gyno mikozal | Gyno-candizol | Gyno-daktarin | Miconaz | Mikazol | Miragel | Mycoheal | Resolve Thrush | Resolve tinea;
  • (LB) Lebanon: Daktarin | Gyno daktarin | Gyno mikozal | Miconal | Miconaz | Mycoderm | Mycoheal;
  • (LT) Lithuania: Daktarin | Gyno daktarin | Miconal;
  • (LU) Luxembourg: Daktar | Daktarin | Gyno-daktarin;
  • (LV) Latvia: Daktarin | Gyno daktarin | Miconal | Miconazol acis | Miconazole tzf | Monazoli-7;
  • (MA) Morocco: Daktarin | Gyno-daktarin | Miko pen | Miko-penotran;
  • (MX) Mexico: Aloid | Biodantyl C | Biodantyl c | Ciliosten | Daktarin | Dermifun | Falernol | Falerol | Fhreshmin | Fucoderm | Fungicrem | Fungiquim | Gyno-daktarin | Gynodaktarin | K mizol | Lecoder | Lotrimin af | Menazan | Micoffen | Miconazol | Miconazol gi alpha | Miconazol gi eurom | Miconazol gi preci | Miconazol gi serra | Miconazol Mavi | Miconazol protein | Micosid | Nacomic | Neomicol | Nimicon | Niscamil | Oz | Xanelle | Zonilan;
  • (MY) Malaysia: Antifungal | Axcel Miconazole | Becarin | Cyprozol | Daktarin | Decozol | Dermon | Fungicide | Gyno-daktarin | Mecandin | Micazo | Mico | Miconazole | Miconor | Micosten | Micozol | Minazol | Mizole | Mycoheal | Resolve tinea | Setarin | Tinazol | Uniderm | Zarin;
  • (NG) Nigeria: Dakdan | Fungusol powder | Miconazole | Zeenat miconazole nitrate;
  • (NL) Netherlands: Antischimmelcreme Miconazolnitraat | Antischimmelpoeder Miconazolnitraat | Daktarin | Dermacure | Etos antischimmelcreme | Gyno daktarin 1 | Gyno daktarin 3 | Gyno-dactarin-3 | Gyno-daktarin | Gyno-miconazol | Livsane antischimmelcreme miconazolnitraat | Miconazolnitr | Miconazolnitraat | San miconazol;
  • (NO) Norway: Daktar;
  • (NZ) New Zealand: Daktarin | Fungo | Gyno-dakratin | Miconazole | Micozole | Micreme | Resolve jock itch | Resolve Thrush | Resolve tinea;
  • (PA) Panama: Mixotone;
  • (PE) Peru: Daktarin;
  • (PH) Philippines: Daktarin | De Ol | Defungin | Emizole | Fungtopic | Micoson | Micostat | Micotran | Monistat;
  • (PK) Pakistan: Arbolim | Bicrole | Candistat | Daktarin | Dermicon | Gyno-daktarin | Gynostin | Imitec | Macnaz | Markonza | Maxizole | Mecroz | Miazol | Micoden | Micogel | Miconal | Miconit | Miconor | Micoral | Monitin | Mycon | Myzovag | Tinearin | Wartze | Zarin;
  • (PL) Poland: Daktarin | Daktarin oral | Gyno daktarin | Miconal | Mikonazol;
  • (PR) Puerto Rico: Antifungal | Azolen | Carrington antifun | Carrington antifungal | Clearly Confident fungus treatment | Desenex | Desenex jock itch | Elta Trivase | Femizol-m | Inzo Antifungal | Miconazole | Miconazole 7 | Miranel | Monistat | Monistat 3 | Neosporin AF | Nuzole | Remedy antifungal | Remedy phytoplex antifungal | Remedy phytoplex antifungal powder;
  • (PT) Portugal: Daktarin | Gyno daktarin | Micane;
  • (PY) Paraguay: Clotrizol | Daktarin | Deralbine | Funazol | Fungolisina | Hongosan mic | Mico aportil | Miconazol kirei | Nocand | Nocand n.f.;
  • (QA) Qatar: Candizol | Candizole | Daktarin | Dermozol | Gyno-Candizol Ovule | Gyno-Daktarin | Gyno-Mikozal | Gynozol | Micogel | Miconaz | Micopex | Micozol | Mikozal | Mycoheal;
  • (RO) Romania: Medacter;
  • (RU) Russian Federation: Dactarin | Daktanol | Daktarin | Ginesol | Gino Dactanol | Gynezol | Gyno daktarin | Micoson | Micozon | Mycoson;
  • (SA) Saudi Arabia: Candizole | Conazol | Daktarin | Dermizol | Fungyzole | Gyno daktarin | Gyno mikozal | Gyno mykozal | Gyno-candizol | Miconaz | Micover | Micozol | Mikozal | Miragel | Mycoheal | Mycoless;
  • (SE) Sweden: Daktar;
  • (SG) Singapore: Anti fungal cream | Candiplas | Daktarin | Decozol | Fungitop | Fungtopic | Micon | Miconazole | Minazol | Mycoban | Resolve | Resolve Thrush | Resolve tinea | SP-Micozol | Zarin;
  • (SI) Slovenia: Daktarin | Rojazol;
  • (SK) Slovakia: Gyno daktarin;
  • (SR) Suriname: Gelora | Gyno daktarin | Micogel | Micolin | Miconal | Miconazole | Miconazolnitraat | Miconazolnitraat apotex | Micospec | Tinazol;
  • (TH) Thailand: Candiplas | Coxalund | Daktarin | Dermon | Funcort | Funga | Fungi-m | Fungisil | Gyno daktarin | Ladoca | Liconar | Micazin | Micoderm | Miconazole | Micosone | Micotin | Minaza | Minazole | Mycella | Mysocort | Nikarin | Noxraxin | Podakrin | Tara;
  • (TN) Tunisia: Daktarin | Gynozol | Miconal | Mycoheal;
  • (TR) Turkey: Fungusit | Miko-penotran;
  • (TW) Taiwan: Antifungal | Camisten | Candiplas | Dafrin | Dakion | Fmina | Gyno daktarin | Gynomycoderin | Konazole | Miconal | Miconazole | Mycoderin;
  • (UA) Ukraine: Fungibel | Gynezol | Gyno daktarin | Gynozol | Micogel | Miconazole;
  • (UG) Uganda: Axel miconazole | Buccazole | Dacinazole | Daktarin | Dermidex | Fungarin | Gyno daktarin | Gynozol | Micazole | Micogel | Micona | Miconaz | Monizol | Orocan | Zarin;
  • (UY) Uruguay: Daktarin | Nomicol;
  • (VE) Venezuela, Bolivarian Republic of: Canidazol | Daktarin | Drinax | Gyno-daktarin | Miconazol | Miconex | Micozen | Nitrato de miconazol;
  • (VN) Viet Nam: Nysiod M;
  • (ZA) South Africa: Covarex | Daktarin | Dermazole | Gyno-daktarin | Gynospor | Miconel;
  • (ZM) Zambia: Daktarin | Decozol | Fungigen | Fungistat | Gyno daktarin | Micofil | Micolin | Miconaz | Miconazole | Micoral | Micosil | Micoson | Micozol | Mycoheal | Tinazol;
  • (ZW) Zimbabwe: Daktarin | Gyno daktarin | Gyno micovar | Miconazole | Micovar
  1. 3M Cavilon (miconazole) [prescribing information]. St. Paul, MN: 3M Health Care; June 2020.
  2. Aloe Vesta Clear (miconazole) [prescribing information]. Skillman, NJ: ConvaTec Inc; November 2020.
  3. Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. J Pediatr. 2001;139(2):317-319. [PubMed 11487763]
  4. Andrews MD, Burns M. Common tinea infections in children. Am Fam Physician. 2008;77(10):1415-1420. [PubMed 18533375]
  5. Berens P, Eglash A, Malloy M, Steube AM. ABM clinical protocol #26: persistent pain with breastfeeding. Breastfeed Med. 2016;11(2):46-53. doi:10.1089/bfm.2016.29002.pjb [PubMed 26881962]
  6. Bradley JS, Nelson JD, Barnett ED, et al, eds. Nelson's Pediatric Antimicrobial Therapy. 30th ed. American Academy of Pediatrics; 2024.
  7. Cavilon (miconazole) [prescribing information]. St. Paul, MN: 3M Health Care; June 2020.
  8. Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. MMWR Morb Mortal Wkly Rep. 1982;31(22):290-291. http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm [PubMed 6810084]
  9. Cowan TL, Murrell DF, Lara Rivero A. Allergic contact dermatitis to miconazole for nipple candidiasis. Contact Dermatitis. 2022;87(2):201-202. doi:10.1111/cod.14125 [PubMed 35417617]
  10. Czeizel AE, Kazy Z, Puhó E. Population-based case-control teratologic study of topical miconazole. Congenit Anom (Kyoto). 2004;44(1):41-45. doi:10.1111/j.1741-4520.2004.00007.x [PubMed 15008899]
  11. Daniel S, Rotem R, Koren G, Lunenfeld E, Levy A. Vaginal antimycotics and the risk for spontaneous abortions. Am J Obstet Gynecol. 2018;218(6):601.e1-601.e7. doi:10.1016/j.ajog.2018.02.013 [PubMed 29510088]
  12. Desenex (miconazole) [prescribing information]. Johnson City, TN: Crown Laboratories Inc; February 2020.
  13. Douglas P. Overdiagnosis and overtreatment of nipple and breast candidiasis: a review of the relationship between diagnoses of mammary candidiasis and Candida albicans in breastfeeding women. Womens Health (Lond). 2021;17:17455065211031480. doi:10.1177/17455065211031480 [PubMed 34269140]
  14. Fungizyl AC (miconazole) [prescribing information]. Panorama City, CA: PureTek Corporation; received December 2024.
  15. Fungizyl AL (miconazole) [prescribing information]. Panorama City, CA: PureTek Corporation; received March 2025.
  16. Goldstein AO, Goldstein BG. Dermatophyte (tinea) infections. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. http://www.uptodate.com. Accessed August 24, 2021.
  17. Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. Mycopathologia. 2008;166(5-6):353-367. doi:10.1007/s11046-008-9109-0 [PubMed 18478357]
  18. Gupta AK, MacLeod MA, Foley KA, Gupta G, Friedlander SF. Fungal skin infections. Pediatr Rev. 2017;38(1):8-22. doi:10.1542/pir.2015-0140 [PubMed 28044030]
  19. Hill RC, Caplan AS, Elewski B, et al. Expert panel review of skin and hair dermatophytoses in an era of antifungal resistance. Am J Clin Dermatol. 2024;25(3):359-389. doi:10.1007/s40257-024-00848-1 [PubMed 38494575]
  20. "Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. Pediatrics. 1997;99(2):268-278. [PubMed 9024461]
  21. Lotrimin Antifungal aerosol, powder (miconazole topical) [prescribing information]. Whippany NJ: Bayer Healthcare LLC; received October 2019.
  22. Lotrimin Antifungal powder (miconazole topical) [prescribing information]. Whippany NJ: Bayer Healthcare LLC. 2016.
  23. Lotrimin Antifungal spray (miconazole topical) [prescribing information]. Whippany NJ: Bayer Healthcare LLC; 2015.
  24. Micatin cream (miconazole topical) [prescribing information]. Sarasota, FL: WellSpring Pharmaceutical Corporation; 2010.
  25. Miconazole 7 (miconazole topical) [prescribing information]. Parsippany, NJ: Actavis Pharma, Inc; March 2015.
  26. Miconi-AL (miconazole topical) [prescribing information]. Phoenix, AZ: True Marker Pharmaceuticals, Inc; October 2023.
  27. Monistat 1 Combination Pack (miconazole topical) [prescribing information]. Trevose, PA: Insight Pharmaceuticals, LLC; March 2013.
  28. Monistat 3 Combination Pack (miconazole topical) [prescribing information]. Tarrytown, NY: Insight Pharmaceuticals LLC; received May 2024.
  29. Monistat 3 Day Vaginal Cream in Prefilled Applicators (miconazole topical) [prescribing information]. Trevose, PA: Insight Pharmaceuticals, LLC; 2012.
  30. Monistat 7 With 1 Reusable Applicator (miconazole topical) [prescribing information]. Tarrytown, NY: Insight Pharmaceuticals, LLC; received January 2020.
  31. Ongley RC. Efficacy of topical miconazole treatment of tinea pedis. Can Med Assoc J. 1978;119(4):353-354. [PubMed 356949]
  32. Papadopoulos EA, Howley MM, Fisher SC, et al; National Birth Defects Prevention Study. Antifungal medication use during early pregnancy and the risk of congenital heart defects in the National Birth Defects Prevention Study, 1997-2011. Birth Defects Res. 2024;116(2):e2308. doi:10.1002/bdr2.2308 [PubMed 38343154]
  33. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guidelines for the management of candidiasis: 2016 update by the Infectious Disease Society of America. Clin Infect Dis. 2016;62(4):409-417. [PubMed 26810419]
  34. Refer to manufacturer's labeling.
  35. Rotem R, Fishman B, Daniel S, Koren G, Lunenfeld E, Levy A. Risk of major congenital malformations following first-trimester exposure to vaginal azoles used for treating vulvovaginal candidiasis: a population-based retrospective cohort study. BJOG. 2018;125(12):1550-1556. doi:10.1111/1471-0528.15293 [PubMed 29790255]
  36. Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. Pediatr Crit Care Med. 2009;10(2):256-259. [PubMed 19188870]
  37. Stevens RE, Konsil J, Verrill SS, et al, "Bioavailability Study of a 1200 mg Miconazole Nitrate Vaginal Ovule in Healthy Female Adults," J Clin Pharmacol, 2002, 42(1):52-60. [PubMed 11808824]
  38. US Department of Health and Human Services (HHS) Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new. Updated September 16, 2024. Accessed October 28, 2024.
  39. van Schalkwyk J, Yudin MH; Infectious Disease Committee. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. J Obstet Gynaecol Can. 2015;37(3):266-274. doi:10.1016/S1701-2163(15)30316-9 [PubMed 26001874]
  40. van Zuuren EJ, Fedorowicz Z, El-Gohary M. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review. Br J Dermatol. 2015;172(3):616-641. doi:10.1111/bjd.13441 [PubMed 25294700]
  41. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. 2002;65(10):2095-2102. [PubMed 12046779]
  42. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. doi:10.15585/mmwr.rr7004a1 [PubMed 34292926]
  43. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1-137. [PubMed 26042815]
  44. Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database Syst Rev. 2001;(4):CD000225. doi:10.1002/14651858.CD000225 [PubMed 11687074]
  45. Zeasorb AF (miconazole) [prescribing information]. Johnson City, TN: Crown Laboratories Inc; received December 2018.
  46. Zhou T, Chen C, Chen X, et al. Possible adverse events of imidazole antifungal drugs during treatment of vulvovaginal candidiasis: analysis of the FDA Adverse Event Reporting System. Sci Rep. 2024;14(1):14560. doi:10.1038/s41598-024-63315-1 [PubMed 38914572]
Topic 12610 Version 518.0